Welcome and Announcements

Update on HIPAA Administration and Enforcement Valerie Montoya, Equal Opportunity Specialist - Investigator, OCR - DHHS/OS

• Understand what uses/disclosures of PHI are permitted during the pandemic
• Identify breach trends
• Implement best practices for your compliance program

Break

Demystifying Drug Diversion, A Compliance Professional’s Perspective Alexandre Raymond, Dir Syst Drug Diversion Prog, Ochsner Health Syst

• Define Healthcare related Drug Diversion
• Associate the Seven Basic Compliance Program Elements to Drug Diversion Prevention and Response Program
• Define Technologies and Future Goals for Proactive Drug Diversion Monitoring
• Apply Methods for Proactive Drug Diversion Monitoring
• Discuss Drug Diversion Pitfalls During a National Pandemic

Break

COVID-19 Related Compliance Risks and Associated Audit Plan Considerations Ryan Haggerty, Consulting Principal , RSM US LLP

• Understand the connection between COVID-19 related topics and associated regulatory compliance risk(s)
• Leverage basic analytics and apply risk assessment feedback to inform the prioritization and selection of COVID-19 related audit areas
• Learn how to approach the design and completion of the COVID-19 related compliance audits selected for your plan

Mid-Conference Break

Networking and Discussion Connect with your fellow attendees and enjoy a free-flowing conversation about what stood out during the morning sessions or a compliance challenge you want feedback on. The objective here is to enable conference participants to network with and learn from each other and help overcome the isolation of the past months. This optional networking event will be held on Zoom and participants may choose to be on camera.

The Basics of EMTALA and Beyond Kathy Poppitt, Partner, King & Spalding LLP

• Understand the basics of EMTALA requirements and how they apply, or don’t, to your facility; Define the stated EMTALA requirements and how to meet them;
• Apply the EMTALA requirements to specific scenarios;
• Recognize when EMTALA does not apply; and
• Understand how the new federal No Surprise Billing Law may affect EMTATL requirements

Break

HIPAA Breach: What do I do now? Lanzi Meyers, Attorney, Gachassin Law Firm

• A walk-through of how to determine if a HIPAA breach has occurred
• Guidance on investigating and conducting a risk assessment
• Guidance on required notifications

Break

The Federal Government’s Approach to Healthcare Compliance Chase Zachary , Assistant United States Attorney , Middle District Louisiana Davis Rhorer, Assistant United States Attorney, Middle District of Louisiana

• Understand the United States’ criminal, civil, and administrative enforcement tools to combat health care fraud and drug diversion
• Identify common and emerging areas of health care fraud
• ss the effectiveness of compliance programs based on the Department of Justice’s Evaluation of Corporate Compliance Programs guidelines

Conference Adjourns